View in EDS HTML Full Text PDF Full Text

Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design.

Saved in:
Bibliographic Details
Title: Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design.
Authors: Groarke JD; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA., Crawford J; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA., Collins SM; Global Biometrics and Data Management, Pfizer R&D UK Ltd, Sandwich, Kent, UK., Lubaczewski SL; Early Clinical Development and Biomedicine Artificial Intelligence, Pfizer Inc, Collegeville, PA, USA., Breen DM; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA., Harrington MA; Global Access and Value, Pfizer Inc, Cambridge, MA, USA., Jacobs I; Global Product Development, Pfizer Inc, New York, NY, USA., Qiu R; Clinical Pharmacology, Pfizer Inc, Cambridge, MA, USA., Revkin J; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA., Rossulek MI; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA., Saxena AR; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA.
Source: Journal of cachexia, sarcopenia and muscle [J Cachexia Sarcopenia Muscle] 2024 Jun; Vol. 15 (3), pp. 1054-1061. Date of Electronic Publication: 2024 Mar 18.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders Country of Publication: Germany NLM ID: 101552883 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-6009 (Electronic) Linking ISSN: 21905991 NLM ISO Abbreviation: J Cachexia Sarcopenia Muscle Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38500292
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Groarke+JD%22">Groarke JD</searchLink>; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Crawford+J%22">Crawford J</searchLink>; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Collins+SM%22">Collins SM</searchLink>; Global Biometrics and Data Management, Pfizer R&D UK Ltd, Sandwich, Kent, UK.<br /><searchLink fieldCode="AU" term="%22Lubaczewski+SL%22">Lubaczewski SL</searchLink>; Early Clinical Development and Biomedicine Artificial Intelligence, Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Breen+DM%22">Breen DM</searchLink>; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Harrington+MA%22">Harrington MA</searchLink>; Global Access and Value, Pfizer Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jacobs+I%22">Jacobs I</searchLink>; Global Product Development, Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Qiu+R%22">Qiu R</searchLink>; Clinical Pharmacology, Pfizer Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Revkin+J%22">Revkin J</searchLink>; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rossulek+MI%22">Rossulek MI</searchLink>; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Saxena+AR%22">Saxena AR</searchLink>; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101552883%22">Journal of cachexia, sarcopenia and muscle</searchLink> [J Cachexia Sarcopenia Muscle] 2024 Jun; Vol. 15 (3), pp. 1054-1061. <i>Date of Electronic Publication: </i>2024 Mar 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Ltd+on+behalf+of+Society+on+Sarcopenia%2C+Cachexia+and+Wasting+Disorders%22">John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101552883 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2190-6009 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221905991%22">21905991 </searchLink><i>NLM ISO Abbreviation: </i>J Cachexia Sarcopenia Muscle <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38500292
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jcsm.13435
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1054
    Titles:
      – TitleFull: Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Groarke JD
      – PersonEntity:
          Name:
            NameFull: Crawford J
      – PersonEntity:
          Name:
            NameFull: Collins SM
      – PersonEntity:
          Name:
            NameFull: Lubaczewski SL
      – PersonEntity:
          Name:
            NameFull: Breen DM
      – PersonEntity:
          Name:
            NameFull: Harrington MA
      – PersonEntity:
          Name:
            NameFull: Jacobs I
      – PersonEntity:
          Name:
            NameFull: Qiu R
      – PersonEntity:
          Name:
            NameFull: Revkin J
      – PersonEntity:
          Name:
            NameFull: Rossulek MI
      – PersonEntity:
          Name:
            NameFull: Saxena AR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2024 Jun
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2190-6009
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of cachexia, sarcopenia and muscle
              Type: main
ResultId 1